NASDAQ:KTRA
Delisted

Kintara Therapeutics Stock Predictions

etoro logo Buy KTRA
*Your capital is at risk
$0.215
+0 (+0%)
At Close: Jan 16, 2025
Currently predicting for Fri, 5 Jun 2026

KTRA Prediction Chart

KTRA Predictions History

Latest community submissions for KTRA.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 25, 2024 $0.129 +7.47% $0.122 V 94.38% 1
JS JS Pro
Jan 24, 2024 $0.125 +1.54% $0.120 X 95.83% 0
Jan 23, 2024 $0.138 +7.79% $0.123 X 88.01% 0
Jan 23, 2024 $0.144 +12.47% $0.123 X 83.15% 0
Jan 23, 2024 Bullish $0.123 X 0
JS JS Pro
Jan 11, 2024 $0.147 +0.07% $0.141 X 95.89% 0
Jan 11, 2024 $0.210 +42.95% $0.141 X 51.27% 0
Jan 11, 2024 $0.160 +8.83% $0.141 X 86.78% 0
Jan 11, 2024 $0.168 +14.12% $0.141 X 81.27% 0
JS JS Pro
Jan 10, 2024 $0.152 +9.27% $0.147 V 96.53% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KTRA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KINTARA THERAPEUTICS INC.
Kintara Therapeutics
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intri...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE